CLOZABEN
Live / Registered — Registered (as of 30 Mar 2021)
What this means for you
Registered since 30 Mar 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87914130
- Registration number
- 6303592
- Mark type
- Stylized text
- Filed
- 09 May 2018
- Published for opposition
- 12 Jan 2021
- Registered
- 30 Mar 2021
- Attorney of record
- Michael T. Smith
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Sodium salts for medical purposes
Owner
- SyneuRx International (Taiwan) Corp., New Taipei City, TW
- SyneuRx International (Taiwan) Corp., New Taipei City, TW
- SyneuRx International (Taiwan) Corp., New Taipei City 221, TW
Prosecution history
- 30 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
- 12 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jan 2021 — PUBLISHED FOR OPPOSITION
- 23 Dec 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Dec 2020 — CASE RETURNED TO EXAMINATION
- 09 Dec 2020 — NOTICE OF ALLOWANCE CANCELLED
- 03 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Dec 2020 — SOU EXTENSION 4 GRANTED
- 01 Dec 2020 — SOU EXTENSION 4 FILED
- 01 Dec 2020 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2020 — ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
- 02 Dec 2020 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 01 Dec 2020 — ASSIGNED TO PETITION STAFF
- 02 Nov 2020 — ASSIGNED TO EXAMINER